Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing.

Dranse HJ, Waise TMZ, Hamr SC, Bauer PV, Abraham MA, Rasmussen BA, Lam TKT.

Nat Commun. 2018 Mar 16;9(1):1118. doi: 10.1038/s41467-018-03490-8.

2.

Lactobacillus gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid-Sensing Pathway Regulating Whole-Body Glucose Homeostasis.

Bauer PV, Duca FA, Waise TMZ, Dranse HJ, Rasmussen BA, Puri A, Rasti M, O'Brien CA, Lam TKT.

Cell Metab. 2018 Mar 6;27(3):572-587.e6. doi: 10.1016/j.cmet.2018.01.013.

3.

Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway.

Bauer PV, Duca FA, Waise TMZ, Rasmussen BA, Abraham MA, Dranse HJ, Puri A, O'Brien CA, Lam TKT.

Cell Metab. 2018 Jan 9;27(1):101-117.e5. doi: 10.1016/j.cmet.2017.09.019. Epub 2017 Oct 19.

4.

Activation of Short and Long Chain Fatty Acid Sensing Machinery in the Ileum Lowers Glucose Production in Vivo.

Zadeh-Tahmasebi M, Duca FA, Rasmussen BA, Bauer PV, Côté CD, Filippi BM, Lam TK.

J Biol Chem. 2016 Apr 15;291(16):8816-24. doi: 10.1074/jbc.M116.718460. Epub 2016 Feb 19.

5.

Corrigendum: Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.

Duca FA, Côté CD, Rasmussen BA, Zadeh-Tahmasebi M, Rutter GA, Filippi BM, Lam TK.

Nat Med. 2016 Feb;22(2):217. doi: 10.1038/nm0216-217b. No abstract available.

PMID:
26845410
6.

Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.

Barr JL, Rasmussen BA, Tallarida CS, Scholl JL, Forster GL, Unterwald EM, Rawls SM.

Br J Pharmacol. 2015 Nov;172(22):5414-24. doi: 10.1111/bph.13330. Epub 2015 Oct 22.

7.

Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.

Luck H, Tsai S, Chung J, Clemente-Casares X, Ghazarian M, Revelo XS, Lei H, Luk CT, Shi SY, Surendra A, Copeland JK, Ahn J, Prescott D, Rasmussen BA, Chng MH, Engleman EG, Girardin SE, Lam TK, Croitoru K, Dunn S, Philpott DJ, Guttman DS, Woo M, Winer S, Winer DA.

Cell Metab. 2015 Apr 7;21(4):527-42. doi: 10.1016/j.cmet.2015.03.001.

8.

Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.

Duca FA, Côté CD, Rasmussen BA, Zadeh-Tahmasebi M, Rutter GA, Filippi BM, Lam TK.

Nat Med. 2015 May;21(5):506-11. doi: 10.1038/nm.3787. Epub 2015 Apr 6. Erratum in: Nat Med. 2016 Feb;22(2):217.

9.

Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.

Côté CD, Rasmussen BA, Duca FA, Zadeh-Tahmasebi M, Baur JA, Daljeet M, Breen DM, Filippi BM, Lam TK.

Nat Med. 2015 May;21(5):498-505. doi: 10.1038/nm.3821. Epub 2015 Apr 6.

PMID:
25849131
10.

Hormonal signaling in the gut.

Côté CD, Zadeh-Tahmasebi M, Rasmussen BA, Duca FA, Lam TK.

J Biol Chem. 2014 Apr 25;289(17):11642-9. doi: 10.1074/jbc.O114.556068. Epub 2014 Feb 27. Review.

11.

Jejunal leptin-PI3K signaling lowers glucose production.

Rasmussen BA, Breen DM, Duca FA, Côté CD, Zadeh-Tahmasebi M, Filippi BM, Lam TK.

Cell Metab. 2014 Jan 7;19(1):155-61. doi: 10.1016/j.cmet.2013.11.014. Epub 2013 Dec 19. Erratum in: Cell Metab. 2014 Mar 4;19(3):548.

12.

Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes.

Breen DM, Rasmussen BA, Côté CD, Jackson VM, Lam TK.

Diabetes. 2013 Sep;62(9):3005-13. doi: 10.2337/db13-0523. Review.

13.

Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes.

Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW, Lam TK.

Nat Med. 2012 Jun;18(6):950-5. doi: 10.1038/nm.2745.

PMID:
22610279
14.

Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats.

Rasmussen BA, Breen DM, Luo P, Cheung GW, Yang CS, Sun B, Kokorovic A, Rong W, Lam TK.

Gastroenterology. 2012 Apr;142(4):834-843.e3. doi: 10.1053/j.gastro.2011.12.053. Epub 2012 Jan 12.

PMID:
22245844
15.

Lipid sensing in the gut, brain and liver.

Rasmussen BA, Breen DM, Lam TK.

Trends Endocrinol Metab. 2012 Feb;23(2):49-55. doi: 10.1016/j.tem.2011.11.001. Epub 2011 Dec 12.

PMID:
22169756
16.

Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production.

Breen DM, Yue JT, Rasmussen BA, Kokorovic A, Cheung GW, Lam TK.

Diabetes. 2011 Dec;60(12):3148-53. doi: 10.2337/db11-0852. Epub 2011 Oct 7.

17.

Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice.

Ward SJ, Rasmussen BA, Corley G, Henry C, Kim JK, Walker EA, Rawls SM.

Behav Pharmacol. 2011 Aug;22(4):370-3. doi: 10.1097/FBP.0b013e3283473c10.

18.

β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats.

Rasmussen BA, Baron DA, Kim JK, Unterwald EM, Rawls SM.

Amino Acids. 2011 Feb;40(2):761-4. doi: 10.1007/s00726-010-0589-0. Epub 2010 Apr 13.

19.

Methanandamide blocks amphetamine-induced behavioral sensitization in rats.

Rasmussen BA, Unterwald EM, Kim JK, Rawls SM.

Eur J Pharmacol. 2010 Feb 10;627(1-3):150-5. doi: 10.1016/j.ejphar.2009.10.059. Epub 2009 Oct 30.

20.

Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism.

Rasmussen BA, Kim E, Unterwald EM, Rawls SM.

Brain Res. 2009 Mar 13;1260:7-14. Epub 2009 Jan 18.

21.

Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism.

Rasmussen BA, Perry DC, O'Neil J, Manaye KF, Tizabi Y.

Neurotox Res. 2008 May-Jun;13(3-4):151-61.

PMID:
18522895
22.

Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats.

Rasmussen BA, O'Neil J, Manaye KF, Perry DC, Tizabi Y.

Psychopharmacology (Berl). 2007 Jan;190(1):43-9. Epub 2006 Oct 18.

PMID:
17047931
23.

An autoradiographic analysis of [125I]alpha-bungarotoxin binding in rat brain after chronic nicotine exposure.

Rasmussen BA, Perry DC.

Neurosci Lett. 2006 Aug 14;404(1-2):9-14. Epub 2006 Jun 5.

PMID:
16750882
24.

3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria.

Yang Y, Severin A, Chopra R, Krishnamurthy G, Singh G, Hu W, Keeney D, Svenson K, Petersen PJ, Labthavikul P, Shlaes DM, Rasmussen BA, Failli AA, Shumsky JS, Kutterer KM, Gilbert A, Mansour TS.

Antimicrob Agents Chemother. 2006 Feb;50(2):556-64.

25.

Pulvinones as bacterial cell wall biosynthesis inhibitors.

Antane S, Caufield CE, Hu W, Keeney D, Labthavikul P, Morris K, Naughton SM, Petersen PJ, Rasmussen BA, Singh G, Yang Y.

Bioorg Med Chem Lett. 2006 Jan 1;16(1):176-80. Epub 2005 Oct 10.

PMID:
16216496
26.

4-Alkyl and 4,4'-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis.

Kutterer KM, Davis JM, Singh G, Yang Y, Hu W, Severin A, Rasmussen BA, Krishnamurthy G, Failli A, Katz AH.

Bioorg Med Chem Lett. 2005 May 16;15(10):2527-31.

PMID:
15863310
28.

Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis.

Francisco GD, Li Z, Albright JD, Eudy NH, Katz AH, Petersen PJ, Labthavikul P, Singh G, Yang Y, Rasmussen BA, Lin YI, Mansour TS.

Bioorg Med Chem Lett. 2004 Jan 5;14(1):235-8.

PMID:
14684334
29.

Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography.

Nguyen HN, Rasmussen BA, Perry DC.

J Pharmacol Exp Ther. 2003 Dec;307(3):1090-7. Epub 2003 Oct 14.

PMID:
14560040
30.

Muraymycins, novel peptidoglycan biosynthesis inhibitors: synthesis and SAR of their analogues.

Yamashita A, Norton E, Petersen PJ, Rasmussen BA, Singh G, Yang Y, Mansour TS, Ho DM.

Bioorg Med Chem Lett. 2003 Oct 6;13(19):3345-50.

PMID:
12951123
31.

2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis.

Li Z, Francisco GD, Hu W, Labthavikul P, Petersen PJ, Severin A, Singh G, Yang Y, Rasmussen BA, Lin YI, Skotnicki JS, Mansour TS.

Bioorg Med Chem Lett. 2003 Aug 4;13(15):2591-4.

PMID:
12852973
32.

Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.

Yang Y, Janota K, Tabei K, Huang N, Siegel MM, Lin YI, Rasmussen BA, Shlaes DM.

J Biol Chem. 2000 Sep 1;275(35):26674-82.

34.

Class A beta-lactamases--enzyme-inhibitor interactions and resistance.

Yang Y, Rasmussen BA, Shlaes DM.

Pharmacol Ther. 1999 Aug;83(2):141-51. Review.

PMID:
10511459
35.

Kinetic properties and metal content of the metallo-beta-lactamase CcrA harboring selective amino acid substitutions.

Yang Y, Keeney D, Tang X, Canfield N, Rasmussen BA.

J Biol Chem. 1999 May 28;274(22):15706-11.

36.

6-(1-Hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C beta-lactamases I.

Bitha P, Li Z, Francisco GD, Rasmussen BA, Lin YI.

Bioorg Med Chem Lett. 1999 Apr 5;9(7):991-6.

PMID:
10230626
37.
38.

Crystal structures of the cadmium- and mercury-substituted metallo-beta-lactamase from Bacteroides fragilis.

Concha NO, Rasmussen BA, Bush K, Herzberg O.

Protein Sci. 1997 Dec;6(12):2671-6.

40.

Carbapenem-hydrolyzing beta-lactamases.

Rasmussen BA, Bush K.

Antimicrob Agents Chemother. 1997 Feb;41(2):223-32. Review. No abstract available.

41.

Antimicrobial resistance in anaerobes.

Rasmussen BA, Bush K, Tally FP.

Clin Infect Dis. 1997 Jan;24 Suppl 1:S110-20. Review.

PMID:
8994790
42.

Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

Rasmussen BA, Bush K, Keeney D, Yang Y, Hare R, O'Gara C, Medeiros AA.

Antimicrob Agents Chemother. 1996 Sep;40(9):2080-6.

43.

Crystal structure of the wide-spectrum binuclear zinc beta-lactamase from Bacteroides fragilis.

Concha NO, Rasmussen BA, Bush K, Herzberg O.

Structure. 1996 Jul 15;4(7):823-36.

45.

SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, Rahal JJ, Bush K.

Antimicrob Agents Chemother. 1995 Apr;39(4):899-905. Erratum in: Antimicrob Agents Chemother 1995 Jul;39(7):1646.

49.

Supplemental Content

Loading ...
Support Center